Author:
Thompson Susan,Bardia Aditya,Tan Angelina,Barton Debra L.,Kottschade Lisa,Sloan Jeff A.,Christensen Brad,Smith DeAnne,Loprinzi Charles L.
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Abou-Khalil B (2005) Benefit–risk assessment of levetiracetam in the treatment of partial seizures. Drug Safety 28:871–890 (Review)
2. Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002) A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 11:273–281
3. Barton DL, Loprinzi CL, Novotny P, Shanafelt T, Sloan J, Wahner-Roedler D, Rummans TA, Christensen B, Dakhill SR, Martin LS (2003) Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol 1:47–51
4. Barton DL, Loprinzi CL, Quella SK et al (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16:495–500
5. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293–297
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Measuring symptoms and toxicities: a 35-year experience;Supportive Care in Cancer;2023-07-27
2. Zentrales Nervensystem;Arzneimitteltherapie in der Palliativmedizin;2022
3. Levetiracetam;Journal of Pain and Symptom Management;2018-10
4. Zentrales Nervensystem;Arzneimitteltherapie in der Palliativmedizin;2018
5. Zentrales Nervensystem;Arzneimitteltherapie in der Palliativmedizin;2015